Shanghai Zheye Biotechnology Limited-Liability Company
发明人:
申请号：
EP17887773.4
公开号：
EP3564242A4
申请日:
2017.12.29
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Provided are a compound of formula (I), a stereoisomer, a tautomer or a pharmaceutically acceptable salt thereof, use thereof as a selective inhibitor for FGFR4 kinase and use thereof in manufacturing a medicament or pharmaceutical composition for treating diseases due to FGFR4 or FGF19. The compound disclosed by the invention has selective and significant inhibitory activities against FGFR4, and has wide application prospect in the field of tumor treatment.
